PrimeRFP - AI-Powered RFP Solutions
PrimeRFP SCOUT · Federal Contract Recompete Brief

SPE2DB24FYX234565020507!exparel 266 MG 20 ML VIAL 20ml — Dms Pharmaceutical Group Inc

Dms Pharmaceutical Group Inc holds $737.3M across 100,503 federal awards, concentrated at Department of Defense (DOD). This PIID sits alongside 1 related award under parent SPE2DB22D9133. PoP ended Jul 17, 2024 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Dla Troop Support
Awarding office
Dms Pharmaceutical Group Inc
Recipient
Jul 17, 2024
PoP end
$249K
Obligated
$249K
Potential
424210
NAICS
6505
PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Dms Pharmaceutical Group Inc — $90

Contract facts

Federal
Contract numberSPE2DB24FYX23
Also listed asSPE2DB22D9133-SPE2DB24FYX23
AgencyDla Troop Support
Awarding officeDla Troop Support
Awarding agencyDepartment of Defense (DOD)
Funding agencyDepartment of Defense (DOD)
IncumbentDms Pharmaceutical Group Inc
CAGE1UNB0
UEIPX72BSBQTKJ3
NAICS424210

No full NAICS 424210 intel page yet. Browse NAICS intelligence

PSC6505
Parent IDIQ / IDVSPE2DB22D9133
Place of performancePARK RIDGE IL
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
PoP startJun 25, 2024
PoP end (current)Jul 17, 2024
Obligated$249K
Current value$249K
Potential value$249K

4565020507!EXPAREL 266 MG/20 ML VIAL 20ML is a federal award for Dla Troop Support held by Dms Pharmaceutical Group Inc. Estimated value $249K ($249K obligated). Current period of performance ends Jul 17, 2024. Place of performance: PARK RIDGE IL.

4565020507!EXPAREL 266 MG/20 ML VIAL 20ML

Recompete timing

Public
● Past PoP end (765 days ago)

Current PoP ended Jul 17, 2024 (765 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Dms Pharmaceutical Group Inc — $737.3M obligated across 100,503 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($737.3M) · all agencies
Department of Defense (DOD)$737.1M · 100%Department of Veterans Affairs (VA)$193K · 0%
Open full company profile →

Related awards

Same parent · incumbent
SPE2D026F0120
8511978882!OTHER MEDICAL
$248K
Apr 26, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract SPE2DB24FYX23?

SPE2DB24FYX23 (4565020507!exparel 266 MG 20 ML VIAL 20ml) is a Dla Troop Support award with a potential value of $249K, currently held by Dms Pharmaceutical Group Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded SPE2DB24FYX23?

Dla Troop Support awarded SPE2DB24FYX23 to Dms Pharmaceutical Group Inc (potential $249K).

Who is the incumbent on SPE2DB24FYX23?

Dms Pharmaceutical Group Inc is the incumbent with $737.3M across 100503 related awards in SCOUT’s public footprint. The current period of performance ends Jul 17, 2024.

When does Dms Pharmaceutical Group Inc’s SPE2DB24FYX23 come up for recompete?

SCOUT tracks a period-of-performance end of Jul 17, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/SPE2DB24FYX23